UK: Swinney renews call to scrap windfall tax after crunch talks with North Sea leaders
First Minister John Swinney has renewed his call for the UK Government to scrap the Energy Profits Levy…
AstraZeneca taps Pathos for breast cancer degrader
Why it matters: The deal allows AstraZeneca to retain shared rights to a next-generation estrogen receptor therapy while…
UK companies continue to see a contract boom from Britain’s biggest rewiring since electrification
The latest investment sees energy infrastructure specialists M Group being awarded a £110m contract to deliver vital overhead…
National Grid: Growth and Customer Protection Must Go Hand in Hand
WASHINGTON, July 23, 2026 /PRNewswire/ — National Grid today reaffirmed its commitment to ensuring that growing electricity demand…
Neurimmune turns future royalties into $425m pipeline cash
Why it matters: The deal allows Neurimmune to raise substantial non-dilutive funding without issuing shares. Since the responsibility…
UK: Scottish Power plans to repower iconic Whitelee
Scottish Power plans to repower and double capacity of the UK’s flagship onshore windfarm, Whitelee, in a £1.5bn project…
UK: Entr and Unitech Power Systems to support Scotland’s Bellrock Offshore Wind Farm
Aker Solutions’ consultancy arm, Entr and its wholly owned subsidiary Unitech Power Systems have been awarded a contract…
Sidley steers Sino Biopharm, AstraZeneca licence agreement
Sidley Austin has advised Sino Biopharmaceutical (Sino Biopharm) on an exclusive licence agreement between its subsidiary, Chia Tai…
AstraZeneca reunites with Dizal in $1.5bn lung cancer deal
Why it matters: The deal gives British-Swedish AstraZeneca a potential companion to its blockbuster EGFR inhibitor Tagrisso, extending…
Astrazeneca strikes exclusive licensing deal with Dizal Pharmaceutical
Drugmaker Astrazeneca said on Tuesday that it has signed an exclusive licensing deal with Dizal Pharmaceutical for Zegfrovy,…
UK: Labour MP takes case for North Sea oil and gas direct to incoming PM Andy Burnham
A Labour member of Westminster’s Energy Security and Net Zero Committee has revealed he took evidence presented during…
GSK ends Alector neuroscience deal after trial failures
Why it matters: The move is another reminder of how difficult neurodegeneration remains for big pharma, even as…